PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
525.00
-5.00 (-0.94%)
Last updated: Jun 16, 2025

IDX:OBAT Cash Flow Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
30,63529,42611,97412,38415,649
Depreciation & Amortization
2,4032,3292,1001,273742.44
Other Operating Activities
-30,745-18,792-57.2815.82,257
Operating Cash Flow
2,29312,96214,01714,47318,648
Operating Cash Flow Growth
-89.30%-7.52%-3.15%-22.39%-
Capital Expenditures
-8,459-6,607-7,488-7,325-3,740
Cash Acquisitions
-606.87-606.87250--
Investment in Securities
5.51178.7920.26-375.08-
Other Investing Activities
-1,015-1,815-250-22535
Investing Cash Flow
-10,075-8,850-7,468-7,925-3,705
Short-Term Debt Issued
---5,978-
Long-Term Debt Issued
-8,2104,375--
Total Debt Issued
8,2108,2104,3755,978-
Short-Term Debt Repaid
-----5,582
Long-Term Debt Repaid
--588.43-75--
Total Debt Repaid
-6,968-588.43-75--5,582
Net Debt Issued (Repaid)
1,2427,6224,3005,978-5,582
Issuance of Common Stock
79,00019,500-1,500-
Common Dividends Paid
-25,050-25,050-7,850-15,000-8,000
Other Financing Activities
-7,257-3,800---
Financing Cash Flow
47,935-1,728-3,550-7,522-13,582
Miscellaneous Cash Flow Adjustments
---0-
Net Cash Flow
40,1532,3842,998-974.191,361
Free Cash Flow
-6,1666,3556,5287,14814,908
Free Cash Flow Growth
--2.65%-8.67%-52.05%-
Free Cash Flow Margin
-4.93%5.27%11.47%18.57%39.38%
Free Cash Flow Per Share
-10.2810.5915.1815.4432.20
Cash Interest Paid
1,5111,3811,253845.28279.34
Levered Free Cash Flow
--2,6582,9953,865-
Unlevered Free Cash Flow
--1,7953,7794,393-
Change in Net Working Capital
-21,128-99.93-1,938-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.